Real-world study of heart valve repair devices for multiple valves
Part of Heart & circulation clinical trials.
This study checks how well and how safely CORCYM valve devices work in real-world patients with heart valve problems in the aortic, mitral, and/or tricuspid positions. It may help doctors understand expected outcomes outside of tightly controlled research settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign an informed consent form that is approved for this study
- You must be able and willing to follow the study’s follow-up visits on schedule
- Your heart condition must match the situations where CORCYM aortic/mitral/tricuspid devices are allowed by the device instructions
- You cannot be in another study that could affect these results
- Your expected life expectancy must be more than 12 months
- You must not have any reasons (from the device instructions) that would make CORCYM devices unsafe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a new valve works when placed inside a previous mitral or tricuspid valve repair or replacement. It may help people who need another procedure on these heart valves.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial tests a new device for people whose mitral valve leaks badly (grade 3+ or 4+) and who are not candidates for surgery. The device aims to fix the leak through a less invasive approach, and the study checks if it's safe and works well in daily life.
This study enrolls adults in the hospital with certain heart valve problems to track their health over time. It may help doctors better understand how valve disease behaves and what outcomes look like in real life.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This study tracks how well new heart valve replacement and repair devices work after they're implanted. Researchers will monitor your health over time to ensure the device is safe and functioning properly.
Hear when a new Cardiac Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.